Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network Meta-Analysis

Objective: The aim was to evaluate the efficacy and safety of vancomycin or daptomycin (VAN/DAP), antistaphylococcal β-lactam (ASBL), trimethoprim-sulfamethoxazole (TMP-SMX), and combination therapy of VAN/DAP + ASBL in the management of methicillin-resistant Staphylococcus aureus (MRSA). Methods: D...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaonan, Lu, Ni, Song, Pan, Zhou, Mingzhen, Li, Yuanxiao, Wang, Zirui, Gao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152223/
https://www.ncbi.nlm.nih.gov/pubmed/35656305
http://dx.doi.org/10.3389/fphar.2022.805966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152223/
https://www.ncbi.nlm.nih.gov/pubmed/35656305
http://dx.doi.org/10.3389/fphar.2022.805966

Ejemplares similares